Canopy Growth Q2 FY27 net loss widens to CAD 40.69 million
- Canopy Growth's Q2 FY27 net loss widened year-over-year to CAD 40.69 million, primarily due to fair-value charges on Canopy USA-related assets.
- Net revenue rose 22% year-over-year to CAD 81.37 million, while the Cannabis segment posted 30% growth to CAD 66.24 million.
- International markets cannabis net revenue more than doubled to CAD 12.27 million, primarily driven by strong sales in Germany and Poland.
- The Smiths Falls facility received EU GMP certification, expanding the international supply chain, while medical cannabis distribution expanded into the U.K.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Canopy Growth Corp. published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.